A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular JIA (Limit-JIA)

Grant

Awarded By

Total Award Amount

  • 16490.00

    • Direct Costs

  • 12685.00

    • Sponsor Award Id

    • Contributor

  • Emily Smitherman   Investigator  
  • Matthew Stoll   Investigator  
  • Melissa Mannion   Principal Investigator  
  • Randy Cron MD, PhD   Investigator